This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Series

Stefan Zielonka, PhD
Associate Director at Merck KGaA/EMD Serono


Stefan received his PhD in 2015 from the Technische Universität of Darmstadt, Germany, where he worked in
the Group of Harald Kolmar in the field of protein engineering of non-canonical antibodies. At the moment he
works as Principal Scientist / Group Leader at Merck KGaA (EMD Serono), Germany, in the Department Protein
Engineering and Antibody Technologies (PEAT).